Aqr Capital Management LLC Verastem, Inc. Transaction History

Aqr Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.05 - $3.2 $60,663 - $94,694	-29,592 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.54 - $4.07 $75,163 - $120,439	29,592 New	29,592 $91,000
Q2 2019 Aug 14, 2019	SELL	$1.25 - $3.14 $48,028 - $120,648	-38,423 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$2.79 - $4.09 $51,679 - $75,759	-18,523 Reduced 32.53%	38,423 $114,000
Q4 2018 Feb 14, 2019	SELL	$3.23 - $7.01 $33,837 - $73,436	-10,476 Reduced 15.54%	56,946 $191,000
Q2 2018 Aug 14, 2018	BUY	$2.88 - $8.67 $194,175 - $584,548	67,422 New	67,422 $464,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.2B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.